Emerging Infectious Disease ISSN: 1080-6059

Mycobacterium cosmeticum, Ohio and Venezuela

Robert C. Cooksey*

, Jacobus H. de Waard†, Mitchell A. Yakrus*, Sean R. Toney*, Omaira Da Mata†, Scott Nowicki‡, Kevin Sohner‡, Elizabeth Koch‡, Cathy A. Petti§, Roger E. Morey*, and Arjun Srinivasan*

Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Instituto de Biomedicina, Caracas, Venezuela; ‡Ohio Department of Health, Columbus, Ohio, USA; §ARUP Laboratories, Salt Lake City, Utah, USA;

Main Article

Figure

Repetitive element (Rep)–PCR (A) and pulsed-field gel electrophoresis (PFGE) (B) patterns of Mycobacterium cosmeticum isolates from 2 patients in Ohio and 1 patient in Venezuela. Rep-PCR was performed by using BOXA1R primer (3), and PFGE was performed with restriction enzyme AseI. Lanes 1, 2, Ohio isolates OH1 and OH2; lanes 3, 4, control strains ATCC BAA-878T and ATCC BAA-879; lane 5, Venezuelan isolate VZ1. DNA size standards are 100-bp (S1) and 48.5-kb marker (S2).

Figure. Repetitive element (Rep)–PCR (A) and pulsed-field gel electrophoresis (PFGE) (B) patterns of Mycobacterium cosmeticum isolates from 2 patients in Ohio and 1 patient in Venezuela. Rep-PCR was performed by using BOXA1R primer (3), and PFGE was performed with restriction enzyme AseI. Lanes 1, 2, Ohio isolates OH1 and OH2; lanes 3, 4, control strains ATCC BAA-878^T and ATCC BAA-879; lane 5, Venezuelan isolate VZ1. DNA size standards are 100-bp (S1) and 48.5-kb marker (S2).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.